PA
ELV icon

Procyon Advisors’s Elevance Health ELV Stock Holding History

Procyon Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-794
Closed -$345K – 511
2025
Q1 		$345K Sell
794
-610
-43% -$245K 0.02% 462
2024
Q4 		$518K Sell
1,404
-474
-25% -$198K 0.03% 324
2024
Q3 		$977K Buy
1,878
+1
+0.1% +$534 0.07% 239
2024
Q2 		$1.02M Buy
1,877
+20
+1% +$10.6K 0.08% 218
2024
Q1 		$963K Sell
1,857
-13
-0.7% -$6.46K 0.07% 227
2023
Q4 		$882K Buy
1,870
+168
+10% +$77.7K 0.07% 221
2023
Q3 		$741K Buy
1,702
+1,130
+198% +$513K 0.08% 242
2023
Q2 		$254K Sell
572
-90
-14% -$41.5K 0.03% 385
2023
Q1 		$304K Sell
662
-50
-7% -$23.8K 0.05% 310
2022
Q4 		$365K Buy
+712
New +$362K 0.07% 260
2020
Q3 		– Sell
-242
Closed -$64K – 430
2020
Q2 		$64K Buy
242
+146
+152% +$39K 0.03% 344
2020
Q1 		$22K Buy
96
+54
+129% +$14.7K 0.01% 465
2019
Q4 		$13K Buy
+42
New +$11.6K 0.01% 582

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Procyon Advisors's ELV Position: Q2 2025 in Review

Procyon Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 794 shares — an estimated $345K sold.

Procyon Advisors first reported a position in ELV in Q4 2019 and held it in 13 quarters. The position peaked at $1.02M in Q2 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Procyon Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Procyon Advisors sold 794 Elevance Health shares in Q2 2025, an estimated $345K.
  • Procyon Advisors first reported a position in Elevance Health in Q4 2019 and held it in 13 quarters.
  • Procyon Advisors's Elevance Health position peaked at $1.02M in Q2 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Procyon Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.